|
Validation of RNA and DNA Biomarkers of Prognosis in Chronic Lymphocytic Leukemia
|
5R01CA123252-02
|
$265,423
|
$265,423
|
ABRUZZO, LYNNE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
preTCR as an inducer of cell survival and transformation
|
7R01CA105129-03
|
$316,480
|
$316,480
|
AIFANTIS, IOANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-04
|
$234,166
|
$18,733
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Epidemiologic Studies of Techa River Cohorts
|
N01CP045505-000
|
$102,671
|
$35,935
|
AKLEYEV, ALEXANDER
|
Urals Research Center for Radiation Mede
|
|
Studies of Occupational Cancer (Pesticides)
|
Z01 CP010119
|
$1,978,544
|
$196,271
|
Alavanja
|
DCEG (NCI)
|
|
Studies of Alpha-tocopherol and Beta-Carotene in Finland
|
Z01 CP010195
|
$742,362
|
$29,879
|
Albanes
|
DCEG (NCI)
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$3,633
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$1,132
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$3,279
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$882
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$41,244
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Santa Rosa Memorial Hospital Regional CCOP
|
3U10CA063850-12S2
|
$131,400
|
$1,314
|
ANDERSON, IAN
|
SANTA ROSA MEMORIAL HOSPITAL
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$3,105,715
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Mechanisms in Perinatal Carcinogenesis
|
Z01 BC 005352
|
$286,829
|
$86,049
|
Anderson, Lucy
|
CCR (NCI)
|
|
Molecular Studies of Cellular Cytotoxicity
|
Z01 BC 010013
|
$541,603
|
$108,321
|
Anderson, Stephen
|
CCR (NCI)
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$19,709
|
Anderson
|
DCEG (NCI)
|
|
THE THERAPY OF AML
|
2P01CA055164-15A1
|
$2,404,845
|
$2,404,845
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
BLys inhibition using TACI-Fc in patients with B-bell non-Hodgkins' Lymphoma
|
1R21CA121569-01A1
|
$281,200
|
$281,200
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
$445,205
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
Z01 SC 010379
|
$313,257
|
$125,303
|
Aplan, Peter
|
CCR (NCI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-03
|
$256,930
|
$256,930
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Adult Leukemia Research Center
|
2P01CA018029-32
|
$5,086,500
|
$5,086,500
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mechanisms of PASG-Mediated Senescence in Hematopoietic Development and Leukemia
|
1R01CA120535-01A2
|
$311,600
|
$311,600
|
ARCECI, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fai
|
Z01 BC 010692
|
$68,001
|
$13,600
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
Z01 BC 010694
|
$544,006
|
$272,003
|
Arthur, Diane
|
CCR (NCI)
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
Z01 SC 010282
|
$68,001
|
$68,001
|
Arthur, Diane
|
CCR (NCI)
|
|
Oncogenic NOTCH Signaling
|
5P01CA119070-02
|
$968,589
|
$968,589
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of Notch Leukemia
|
5R01CA082308-09
|
$433,640
|
$433,640
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$10,294
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Southeast Cancer Control Consortium, Inc
|
3U10CA045808-21S1
|
$170,000
|
$3,400
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$37,213
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-33
|
$413,938
|
$33,115
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
MDR Gene Polymorphisms in AML
|
1R21CA127848-01
|
$192,621
|
$192,621
|
BAER, MARIA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA052667-17
|
$484,826
|
$9,697
|
BAEZ, LUIS
|
SAN JUAN CITY HOSPITAL
|
|
Southwest Oncology Group
|
2U10CA027057-28
|
$255,214
|
$10,209
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
3U10CA027057-28S1
|
$43,000
|
$1,720
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Interim SWOG Committee Renewals (Breast, Head & Neck, Leukemia)
|
3U10CA032102-28S1
|
$187,055
|
$7,482
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S2
|
$159,600
|
$6,384
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S3
|
$316,222
|
$12,649
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-02
|
$420,764
|
$210,382
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-28
|
$9,423,958
|
$376,958
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-03
|
$999,441
|
$99,944
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Deregulation of Cellular IkB Kinases by HTLV1 Tax
|
5R01CA082556-08
|
$420,218
|
$420,218
|
BALLARD, DEAN
|
VANDERBILT UNIVERSITY
|
|
PDGF Receptor Regulation by CBL
|
5R01CA099900-06
|
$216,185
|
$54,046
|
Band, Hamid
|
EVANSTON NORTHWESTERN HEALTHCARE
|
|
Molecular Determinants of Methotrexate in ALL
|
5R01CA098152-05
|
$297,317
|
$297,317
|
BARREDO, JULIO
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$33,438
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Prevention of insertional mutagenesis in gene therapy
|
5R01CA107492-03
|
$224,720
|
$224,720
|
BAUM, CHRISTOPHER
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$25,470
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$13,900
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$832,107
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Leukemia for this search: $205,535,584
|